Company-wide revenue
Reported revenue in 2021 ¥155.25B Reported revenue in 2025 ¥165.74B
- growth amount
- +¥10.49B
- growth annualized
- +1.6%
- growth total
- +6.8%
Japanese company profile · 4967
KOBAYASHI PHARMACEUTICAL CO.,LTD.
In its FY2025 public filing, KOBAYASHI PHARMACEUTICAL CO.,LTD. reports Domestic Operations, International Operations. The page shows business-level revenue and profit where the source disclosures support comparison.
Original Japanese company name: 小林製薬株式会社
English company name recorded in Japan's EDINET filer data. English company name source
Reported company-wide figures
What does this company do?
What does this company do?
KOBAYASHI PHARMACEUTICAL CO.,LTD.'s largest reported business by revenue in FY2025 was Domestic Operations.
The business with the highest reported segment profit in FY2025 was Domestic Operations.
FY2025 · fiscal year ended December 2025 View original filing ↗ The source document may be in Japanese.
Business structure
How does it make money?
| Business | Sales | Revenue share | Operating profit |
|---|---|---|---|
| Domestic Operations | ¥122.92B ↗ | 74.2% | ¥13.96B ↗ |
| International Operations | ¥48.41B ↗ | 29.2% | ¥810M ↗ |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended December 2025. Revenue and profit are shown only where the filing and data support a comparison.
Original Japanese label
- Domestic Operations
- 国内事業
- International Operations
- 国際事業
- Mail-order Business
- 通販事業
- Sales
- 売上高
- Operating profit
- 営業利益
Original Japanese label
- Domestic Operations
- 国内事業
- International Operations
- 国際事業
- Mail-order Business
- 通販事業
- Sales
- 売上高
- Operating profit
- 営業利益
Reported Sales by business over time
Reported Sales by business over time
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Domestic Operations | ¥121.96B | ¥124.24B | ¥136.54B | ¥123.92B | ¥122.92B |
| International Operations | ¥31.14B | ¥41.55B | ¥44.13B | ¥46.84B | ¥48.41B |
| Mail-order Business | ¥8.99B | ¥8.44B | — | — | — |
All amounts are in Japanese yen (JPY). Each figure links to the original Japanese filing. Blank cells indicate no comparable figure was disclosed. Business figures may not add up to consolidated figures.
What is growing?
What is growing?
Business revenue growth
International Operations
Reported revenue in 2021 ¥31.14B Reported revenue in 2025 ¥48.41B
- growth amount
- +¥17.27B
- growth annualized
- +11.7%
- growth total
- +55.5%
View original filing
This describes a reported period; it is not a forecast.
What has changed?
What has changed?
Not disclosed or not safely comparable in the available filings.
Source
Public filing
FY2025 · fiscal year ended December 2025
The source document may be in Japanese.
Filing ID: S100XSXS
View original filing ↗Ask about this company
Ask about this company
The source document may be in Japanese.